DruMAP: A Novel Drug Metabolism and Pharmacokinetics Analysis Platform
Journal of Medicinal Chemistry · 27.07.2023 · 66 (14) · 9697-9709
DOI: 10.1021/acs.jmedchem.3c00481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 14.07.2023. Verfasst von Hitoshi Kawashima und 8 weiteren Autor:innen. Beteiligte Einrichtung: Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition, Settsu, Osaka …. Hauptthemen laut MEDLINE: Drug Development, Pharmacokinetics. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
We developed a novel drug metabolism and pharmacokinetics (DMPK) analysis platform named DruMAP. This platform consists of a database for DMPK parameters and programs that can predict many DMPK parameters based on the chemical structure of a compound. The DruMAP database includes curated DMPK parameters from public sources and in-house experimental data obtained under standardized conditions; it also stores predicted DMPK parameters produced by our prediction programs. Users can predict several DMPK parameters simultaneously for novel compounds not found in the database. Furthermore, the highly flexible search system enables users to search for compounds as they desire. The current version of DruMAP comprises more than 30,000 chemical compounds, about 40,000 activity values (collected from public databases and in-house data), and about 600,000 predicted values. Our platform provides a simple tool for searching and predicting DMPK parameters and is expected to contribute to the acceleration of new drug development. DruMAP can be freely accessed at: https://drumap.nibiohn.go.jp/.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Artificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition, Settsu, Osaka 566-0002, Japan.
- Laboratory for Computational Biology, Institute for Protein Research, Osaka University, Suita, Osaka 565-0871, Japan.
- Data Science and AI Innovation Research Promotion Center, Shiga University, Hikone, Shiga 522-8522, Japan.
- Discovery Technology Laboratories, Mitsubishi Tanabe Pharma Corporation, Yokohama, Kanagawa 227-0033, Japan.
- Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Tokushima 770-8503, Japan.
- University Research Administration Center, Osaka Metropolitan University, Osaka, Osaka 545-0051, Japan.
ORCID-Profile: Hitoshi Kawashima, Tsuyoshi Esaki, Masataka Kuroda, Chioko Nagao
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Kawashima, H., Watanabe, R., Esaki, T., Kuroda, M., Nagao, C., Natsume-Kitatani, Y., Ohashi, R., Komura, H., & Mizuguchi, K. (2023). DruMAP: A Novel Drug Metabolism and Pharmacokinetics Analysis Platform. Journal of Medicinal Chemistry, 66(14), 9697-9709. https://doi.org/10.1021/acs.jmedchem.3c00481
Vancouver
Kawashima H, Watanabe R, Esaki T, Kuroda M, Nagao C, Natsume-Kitatani Y, et al. DruMAP: A Novel Drug Metabolism and Pharmacokinetics Analysis Platform. Journal of Medicinal Chemistry. 2023;66(14):9697-9709. doi:10.1021/acs.jmedchem.3c00481
BibTeX
@article{Kawashima2023,
author = {Kawashima, Hitoshi and Watanabe, Reiko and Esaki, Tsuyoshi and Kuroda, Masataka and Nagao, Chioko and Natsume-Kitatani, Yayoi and Ohashi, Rikiya and Komura, Hiroshi and Mizuguchi, Kenji},
title = {DruMAP: A Novel Drug Metabolism and Pharmacokinetics Analysis Platform},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {14},
pages = {9697--9709},
doi = {10.1021/acs.jmedchem.3c00481}
}
EUVIMED